UPDATE 2-Epizyme prices rare tissue cancer treatment at $15,500 a month

Epizyme Inc on Thursday priced its treatment for a ultra rare, slow growing type of cancer that affects soft tissue at $15,500 per month after getting an approval from the U.S. Food and Drug Administration.

from Reuters: Company News https://ift.tt/2sW1YtU
via IFTTT